5-(2-methoxybenzylidene)hydantoin | 21730-69-8

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 唑烷类
• 英文名称: 5-(2-methoxybenzylidene)hydantoin
• 英文别名: 5-(2-methoxy-benzylidene)-imidazolidine-2,4-dione；4-(2-methoxy-benzylidene)-imidazolidine-2,4-dione；4-(2-Methoxy-benzyliden)-imidazolidin-2,4-dion；5(2-methoxy-benzylidene)hydantoin；5-(2'-Methoxybenzal) hydantoin；5-(2-Methoxy-benzyliden)-hydantoin；5-[(2-Methoxyphenyl)methylidene]imidazolidine-2,4-dione
• CAS: 21730-69-8
• 化学式: C₁₁H₁₀N₂O₃
• mdl: MFCD01721164
• 分子量: 218.212
• InChiKey: YOFKIDCKEYKPNO-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  1.1
• 重原子数：
  16
• 可旋转键数：
  2
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.09
• 拓扑面积：
  67.4
• 氢给体数：
  2
• 氢受体数：
  3

安全信息

• 海关编码：
  2933990090

反应信息

• 作为反应物：
  描述：

  5-(2-methoxybenzylidene)hydantoin 在 水 、 sodium hydroxide 作用下， 反应 3.0h， 以0.23 g的产率得到2-羟基-3-(2-甲氧基苯基)丙烯酸
  参考文献：
  名称：

  Design, synthesis, and biological evaluation of substrate-competitive inhibitors of C-terminal Binding Protein (CtBP)

  摘要：

  C-terminal Binding Protein (CtBP) is a transcriptional co-regulator that downregulates the expression of many tumor-suppressor genes. Utilizing a crystal structure of CtBP with its substrate 4-methylthio-2-oxobutyric acid (MTOB) and NAD(+) as a guide, we have designed, synthesized, and tested a series of small molecule inhibitors of CtBP. From our first round of compounds, we identified 2-(hydroxyimino)-3-phenylpropanoic acid as a potent CtBP inhibitor (IC50 = 0.24 mu M). A structure-activity relationship study of this compound further identified the 4-chloro- (IC50 = 0.18 mu M) and 3-chloro- (IC50 = 0.17 mu M) analogues as additional potent CtBP inhibitors. Evaluation of the hydroxyimine analogues in a short-term cell growth/viability assay showed that the 4-chloro- and 3-chloro-analogues are 2-fold and 4-fold more potent, respectively, than the MTOB control. A functional cellular assay using a CtBP-specific transcriptional readout revealed that the 4-chloro- and 3-chloro-hydroxyimine analogues were able to block CtBP transcriptional repression activity. This data suggests that substrate-competitive inhibition of CtBP dehydrogenase activity is a potential mechanism to reactivate tumor-suppressor gene expression as a therapeutic strategy for cancer. (C) 2016 Elsevier Ltd. All rights reserved.

  DOI：

  10.1016/j.bmc.2016.04.037
• 作为产物：
  描述：

  alkaline earth salt of/the/ methylsulfuric acid 在 水 、 氯乙酸 作用下， 生成 5-(2-methoxybenzylidene)hydantoin
  参考文献：
  名称：

  Johnson; Scott, Journal of the American Chemical Society, 1915, vol. 37, p. 1855

  摘要：

  DOI：

文献信息

• Chemoenzymatic synthesis of L-3,4-dimethoxyphenyl-alanine and its analogues using aspartate aminotransferase as a key catalyst
  作者：Jinhai Yu、Jing Li、Shuangyan Cao、Ting Wu、Shuiyun Zeng、Hongjuan Zhang、Junzhong Liu、Qingcai Jiao

  DOI：10.1016/j.catcom.2018.10.033

  日期：2019.2

  In this study, a chemoenzymatic synthesis method for the production of L-3,4-dimethoxyphenyl-alanine and its analogues from phenylpyruvate derivatives was developed. The aspartate aminotransferase from Escherichia coli was engineered by error prone PCR and the improved variants were identified. When 3, 4-dimethoxy phenylpyruvate was added by fed-batch on a preparative scale, L-3,4-dimethoxyphenyl-alanine

  在这项研究中，开发了一种化学酶法合成苯丙酮酸衍生物来生产L-3,4-二甲氧基苯基丙氨酸及其类似物的方法。通过易错PCR对大肠杆菌的天冬氨酸转氨酶进行了工程改造，并鉴定了改良的变体。当以制备规模通过补料分批加入3,4-二甲氧基苯基丙酮酸时，形成L-3,4-二甲氧基苯基丙氨酸，转化率为95.4％，ee> 99％，其中最佳的天冬氨酸转氨酶变体为催化剂。这项研究提供了一种利用工程天冬氨酸转氨酶生产甲氧基取代的苯丙氨酸的有效方法。
• Antiviral 5-(substituted benzal) hydantoins
  申请人：Canada Packers Limited

  公开号：US04013770A1

  公开（公告）日：1977-03-22

  Therapeutic compositions containing a compound of the formula: ##STR1## wherein: R.sub.1, R.sub.2, and R.sub.3 are each hydrogen, hydroxy, alkoxy f 1 to 4 carbon atoms, acyloxy of 1 to 4 carbon atoms, halo, or nitro, or R.sub.2 and R.sub.3 together form --OCH.sub.2 O--; or the corresponding acylated derivatives wherein there are one or more acyl groups in the hydantoin moiety and each acyl group contains from 1 to 20 carbon atoms, and the use of said compounds to control virus infections, in particular those caused by viruses of the Picorna group.

  含有以下化合物的治疗性组合物：##STR1## 其中：R.sub.1、R.sub.2和R.sub.3分别为氢、羟基、1至4个碳原子的烷氧基、1至4个碳原子的酰氧基、卤素或硝基，或者R.sub.2和R.sub.3一起形成--OCH.sub.2 O--；或相应的酰化衍生物，其中在乙酰脲基团中有一个或多个酰基，每个酰基含有1至20个碳原子，并且使用这些化合物来控制病毒感染，特别是由小核糖核酸病毒群引起的感染。
• Process for the preparation of D1-.beta.-aryl amino acids
  申请人：Alkaloida Vegyeszeti Gyar

  公开号：US04647694A1

  公开（公告）日：1987-03-03

  The invention relates to a process for the preparation of DL-.beta.-aryl-amino acids of the general Formula ##STR1## wherein R, R.sub.1 and R.sub.2 stand for hydrogen, halogen, C.sub.1-6 alkyl, C.sub.1-6 alkoxy, nitro or C.sub.1-4 dialkylamino; whereby in the case of monosubstituted derivatives R and R.sub.1 are hydrogen and R.sub.2 has the same meaning as stated above and can be attached to position 2, 3 or 4 related to the methylene group; in the case of disubstituted derivatives R is hydrogen and R.sub.1 and R.sub.2 have the same meaning as stated above and are attached to positions 2,3; 2,4; 2,5; 2,6; 3,4 or 3,5 related to the methylene group; in the case of trisubstituted derivatives R, R.sub.1 and R.sub.2 have the same meaning as stated above and are attached to positions 2,3,4; 2,3,5; 2,3,6; 3,4,5 or 3,4,6 related to the methylene group.

  该发明涉及一种制备DL-.beta.-芳基氨基酸的过程，其通式如下所示：其中R、R.sub.1和R.sub.2代表氢、卤素、C.sub.1-6烷基、C.sub.1-6烷氧基、硝基或C.sub.1-4二烷基氨基；对于单取代衍生物，若R和R.sub.1为氢，则R.sub.2具有上述相同含义，并可附着于与亚甲基基团相关的2、3或4位置；对于双取代衍生物，R为氢，R.sub.1和R.sub.2具有上述相同含义，并附着于2、3；2、4；2、5；2、6；3、4或3、5位置；对于三取代衍生物，R、R.sub.1和R.sub.2具有上述相同含义，并附着于2、3、4；2、3、5；2、3、6；3、4、5或3、4、6位置。
• 5位取代手性海因的制备方法
  申请人：湖南海利化工股份有限公司

  公开号：CN105884692A

  公开（公告）日：2016-08-24

  本发明公开了一种乙内酰脲衍生的环外烯烃的不对称催化氢化直接制备5位取代手性海因化合物的方法。5位取代手性海因化合物的化学结构式用式(I)表示：本发明的化学反应方程式如下：反应式中化合物(Ⅱ)为乙内酰脲衍生的环外烯烃，化合物(Ⅲ)为催化剂，催化剂是手性双膦配体的金属配合物。本发明与现有技术相比具有手性增殖、高效高选择性、原子经济性、绿色无污染、易于工业化等特点。
• Design, synthesis, and biological evaluation of substrate-competitive inhibitors of C-terminal Binding Protein (CtBP)
  作者：Sudha Korwar、Benjamin L. Morris、Hardik I. Parikh、Robert A. Coover、Tyler W. Doughty、Ian M. Love、Brendan J. Hilbert、William E. Royer、Glen E. Kellogg、Steven R. Grossman、Keith C. Ellis

  DOI：10.1016/j.bmc.2016.04.037

  日期：2016.6

  C-terminal Binding Protein (CtBP) is a transcriptional co-regulator that downregulates the expression of many tumor-suppressor genes. Utilizing a crystal structure of CtBP with its substrate 4-methylthio-2-oxobutyric acid (MTOB) and NAD(+) as a guide, we have designed, synthesized, and tested a series of small molecule inhibitors of CtBP. From our first round of compounds, we identified 2-(hydroxyimino)-3-phenylpropanoic acid as a potent CtBP inhibitor (IC50 = 0.24 mu M). A structure-activity relationship study of this compound further identified the 4-chloro- (IC50 = 0.18 mu M) and 3-chloro- (IC50 = 0.17 mu M) analogues as additional potent CtBP inhibitors. Evaluation of the hydroxyimine analogues in a short-term cell growth/viability assay showed that the 4-chloro- and 3-chloro-analogues are 2-fold and 4-fold more potent, respectively, than the MTOB control. A functional cellular assay using a CtBP-specific transcriptional readout revealed that the 4-chloro- and 3-chloro-hydroxyimine analogues were able to block CtBP transcriptional repression activity. This data suggests that substrate-competitive inhibition of CtBP dehydrogenase activity is a potential mechanism to reactivate tumor-suppressor gene expression as a therapeutic strategy for cancer. (C) 2016 Elsevier Ltd. All rights reserved.